Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Oncolytics Biotech Inc T.ONC

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  ONCY

Oncolytics Biotech, Inc., is a development stage biopharmaceutical company that focuses on the discovery and development of pharmaceutical products for the treatment of cancers.
Price: $1.42 | Change: +$0.02 | %Change: +1.43%
Volume: 13,662 | Day High/Low: 1.42/1.39 | 52 Week High/Low: 3.49/1.31

Snapshot

Last Traded: September 16, 2014 08:42 Transaction Volume: 13,662
Open: $1.42 Previous Close: $1.40
Bid: $1.40 Ask: $1.42
Bid Size: 8,200 Ask Size: 3,400
Market Cap: $125.2m Shares Out: 88.1m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Opinion

Canadian Biotech comes back to life: A buyer's guide

Everything you could ever want to know about biotech, biomed and bio investments up north.

Tony Pullen   January 21, 2014
0 stars

Latest Bullboard Posts

  • RE:RE:Answers, Issues, Questions

    0 stars

    Bunge, With 10K shares, you might get to $100G in six months! Lots of news coming up, including panc results in less than two weeks...

    2 stars


  • RE:Fund Security

    0 stars

    Oncy has cash on hand sufficient until October 2015. The float is relatively small and the company has always had the ability to raise...

    2 stars


  • Fund Security

    5 stars

    Thinking about taking a small position, quick question to the board - how secure is ONCY's funding?

    2.5 stars


  • RE:ESMO

    5 stars

    http://www.forbes.com/sites/davidkroll/2014/08/28/gsk-niaid-ebola-vaccine-to-enter-uk-human-safety-trials-broad-international...

    2.5 stars


  • ESMO

    5 stars

    On September 28,2014 at 12:45 Dr Saab will present the results of the Phase 2 First Line treatment for Pancreatic Cancer. If his previous...

    2.5 stars